Upper EndoscopyNutrition and dietWeight loss
What this study is
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
What's being tested
- Modified Fasting Guidelines
Intervention · OTHER
Patients will follow a full-liquid diet 48 hours prior to their procedure, clear liquid diet 24 hours prior to their procedure, and nothing by mouth (NPO) after midnight on the day of their procedure
Study details
- Sponsor
- Mayo Clinic
- Conditions
- Upper Endoscopy · GLP1-R-related Disease
- Enrolling
- 150 people
- Starts
- 2025-08-01
- Est. completion
- 2026-12-31
- Design
- Single-blind, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients undergoing elective upper endoscopy with gastroenterology team
You can't join if
- Urgent or emergent procedure
- Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
- Upper GI barium study performed in past 24 hours.
- Gastroparesis
- Achalasia
- Pancreatitis
- Use of outpatient pro-motility medications
- Patient refusal
- Inability for patient to provide own consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMayo Clinic in Rochester
Rochester, Minnesota, United States
- Krishnan Ramanujan, MD · Contact507-422-4898ramanujan.krishnan@mayo.edu
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID 23-013192
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.